Home > Healthcare > Medical Devices > Diagnostic Devices > Urinary Tract Infection Testing Market
Urinary Tract Infection Testing Market size was valued at over USD 590 million in 2022 and is slated to exhibit more than 5.7% CAGR from 2023 to 2032 driven by increasing prevalence of urinary tract infections globally.
Urinary tract infection (UTI) testing is a diagnostic process used to detect the presence of bacteria or other pathogens in a patient's urine that may be causing an infection in the urinary tract. UTIs are a common infection, particularly among women, and can cause discomfort, pain, and other health complications if left untreated. Additionally, the high prevalence of diabetes is further accelerating market statistics.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Urinary Tract Infection Testing Market Size in 2022: | USD 592 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.7% |
2032 Value Projection: | USD 1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 357 |
Segments covered: | Test type, Test kit type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Moreover, in 2021, as per statistics provided by the International Diabetes Federation (IDF), about 537 million adults aged between 20-79 years lived with diabetes. Furthermore, the high number of type 1 diabetes patients mainly children and adolescents will further propel the market growth since diabetic patients are highly prone to contract UTI. In addition, several market players are emphasizing on research and development activities for the development of novel urinary tract infection testing devices such as test strips.